Ultrasonic Electrosurgical Devices Market Size & Growth Forecast 2027–2036, By Segments (Product, End Use, Type, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Ultrasonic Electrosurgical Devices Market size was valued at USD 4.2 billion in 2026 and is anticipated to grow at a 5.17% CAGR from 2027 to 2036, crossing USD 6.95 billion by 2036. The industry revenue for 2027 is calculated at USD 4.38 billion.

• Base Year Value (2026): USD 4.2 billion
• CAGR (2027-2036): 5.17%
• Forecast Year Value (2036): USD 6.95 billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Ultrasonic Electrosurgical Devices Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America held a 38.80% share in 2026, supported by advanced surgical infrastructure, widespread use of minimally invasive procedures, and consistent adoption of energy-based surgical technologies across healthcare facilities.
  • Asia Pacific is forecast to grow at a 6.22% CAGR due to expanding hospital capacity, rising surgical volumes, broader access to minimally invasive procedures, and increasing investment in modern operating room technologies.

• Segment Momentum:

  • Consumables held a 59.54% share in 2026 because they require continuous replenishment for surgical procedures, creating stable recurring demand across hospitals and other healthcare facilities.
  • Ambulatory Surgical Centers are growing fastest as more procedures shift to outpatient care, increasing demand for advanced ultrasonic devices that support efficient workflows and high procedural throughput.

• Market Expansion Drivers:

  • Rising prevalence of chronic diseases and increasing surgical procedures driving device utilization.
  • Growing preference for minimally invasive surgeries improving adoption of ultrasonic surgical tools.
  • Expanding healthcare infrastructure and surgical capacity in emerging economies boosting device penetration.

• Leading Market Participants:

  Prominent players in the ultrasonic electrosurgical devices market include Johnson & Johnson (United States), Olympus Corporation (Japan), Medtronic plc (Ireland), Söring GmbH (Germany), BOWA-electronic GmbH & Co. KG (Germany), Misonix, Inc. (United States), Reach Surgical, Inc. (United States), SonaCare Medical, LLC (United States), Miconvey Technologies Co., Ltd. (China), Advanced Instrumentations (United States).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 4.2 billion
  • 2027 Estimated Market Size: USD 4.38 billion.
  • Projected Market Size: USD 6.95 billion by 2036
  • Growth Forecasts: 5.17% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Consumables (Product) | Hospitals (End Use) | High-intensity Focused Ultrasonic (HIFU)Ablators (Type) | Cardiology (Application)
  • Emerging Opportunity Segment: Generators (Product) | Ambulatory Surgical Centers (End Use) | Ultrasonic Surgical Ablation Systems (Type) | Gynecology (Application)

Market Growth Drivers and Industry Trends

Rising prevalence of chronic diseases and increasing surgical procedures driving device utilization

The growing burden of chronic diseases and the resulting increase in surgical interventions are supporting the ultrasonic electrosurgical devices market by expanding the need for reliable tissue cutting and coagulation technologies during procedures. As healthcare systems manage greater procedural volumes, surgeons require instruments that can support efficient surgical workflows and precise tissue handling, increasing utilization of ultrasonic devices across relevant surgical applications.

Growing preference for minimally invasive surgeries improving adoption of ultrasonic surgical tools

A stronger preference for minimally invasive procedures will propel the ultrasonic electrosurgical devices market as healthcare providers increasingly prioritize surgical approaches that support precision while reducing the physical impact of interventions. Ultrasonic surgical tools can facilitate controlled tissue dissection and coagulation, making them suitable for procedures where accurate handling and efficient operative performance are important considerations for surgical teams.

Expanding healthcare infrastructure and surgical capacity in emerging economies boosting device penetration

Expansion of healthcare infrastructure and growing surgical capacity in emerging economies are creating additional opportunities for the ultrasonic electrosurgical devices market as hospitals develop capabilities to perform a broader range of procedures. Investments in surgical facilities and equipment increase access to advanced operating technologies, while expanding clinical capacity allows healthcare providers to incorporate ultrasonic tools into modern surgical workflows.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising prevalence of chronic diseases and increasing surgical procedures driving device utilization	2.30%	High	North America, Europe	High	Near Term
Growing preference for minimally invasive surgeries improving adoption of ultrasonic surgical tools	2.00%	High	Asia Pacific, North America	High	Near Term
Expanding healthcare infrastructure and surgical capacity in emerging economies boosting device penetration	1.70%	Moderate	Asia Pacific, Latin America	High	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

The ultrasonic electrosurgical devices market was led by North America, which accounted for a 38.80% share in 2026, supported by advanced surgical infrastructure, high adoption of minimally invasive procedures, and strong demand for technologies that improve precision and operating efficiency. Healthcare providers increasingly favor ultrasonic devices for applications requiring controlled tissue dissection and hemostasis, particularly as surgical practices continue shifting toward procedures that can reduce tissue trauma and support efficient recovery. The region’s established hospital systems, availability of specialized surgical expertise, and emphasis on advanced operating-room technologies further reinforce adoption. In addition, continued investment in modern surgical equipment and increasing awareness of technology-assisted procedures support the region’s strong market position.

Asia Pacific is the fastest-growing regional market, driven by expanding healthcare infrastructure, increasing access to advanced surgical procedures, and rising investment in modern medical technologies. Hospitals across developing healthcare systems are progressively upgrading surgical capabilities, creating opportunities for ultrasonic electrosurgical equipment in a wider range of procedures. Growing demand for minimally invasive interventions is also encouraging the adoption of devices that provide precise tissue handling and effective bleeding control. Improvements in healthcare spending, expansion of specialist surgical services, and increasing patient preference for less invasive treatment approaches are strengthening demand, while the modernization of operating facilities provides additional momentum for market development.

Key Country Insights

United States

Advanced Surgical Adoption

The U.S. ultrasonic electrosurgical devices market is driven by demand for minimally invasive procedures and precision surgical technologies. Healthcare providers in the U.S. continue investing in advanced energy devices that improve operating efficiency and patient outcomes.

Japan

Minimally Invasive Expansion

Japan promotes ultrasonic electrosurgical devices as healthcare providers expand minimally invasive surgical capabilities. Medical institutions in Japan prioritize technologies that enhance surgical accuracy, reduce tissue trauma, and support efficient postoperative recovery.

South Korea

Hospital Technology Upgrades

South Korea continues modernizing surgical infrastructure through broader adoption of advanced electrosurgical technologies. Hospitals in South Korea invest in ultrasonic devices that improve procedural precision while supporting increasingly sophisticated surgical techniques.

Germany

Precision Surgical Technology

Germany integrates ultrasonic electrosurgical devices into modern surgical practice with strong emphasis on clinical precision and workflow efficiency. Hospitals in Germany adopt advanced energy platforms that support complex procedures across multiple surgical specialties.

France

Clinical Workflow Optimization

France incorporates ultrasonic electrosurgical devices into hospital modernization initiatives focused on surgical efficiency and patient care quality. Healthcare providers in France value systems that combine precise tissue management with streamlined operating room workflows.

Italy

Specialized Surgical Equipment

Italy expands the use of ultrasonic electrosurgical devices across general and specialty surgical procedures requiring controlled tissue dissection. Healthcare facilities in Italy prioritize dependable surgical platforms that improve procedural consistency and support evolving clinical practices.

Segment Leadership and Growth Trends

 

Product Segment Analysis: Consumables (Largest Segment) vs Generators (Fastest-Growing Segment)

In the ultrasonic electrosurgical devices market, consumables accounted for the largest share of 59.54% in 2026, reflecting their recurring use during surgical procedures and their essential role in ultrasonic energy-based tissue cutting and coagulation. Surgical teams require dependable consumable components to achieve controlled dissection, hemostasis, and tissue management across a wide range of procedures. Increasing adoption of minimally invasive surgery is supporting demand for devices that enable precise tissue handling while helping streamline surgical workflows. The recurring nature of consumable utilization also contributes to their strong commercial position within the product landscape.

Generators represent the fastest-growing product segment, supported by ongoing demand for advanced energy platforms capable of delivering precise and controlled ultrasonic performance. Improvements in energy management, procedural flexibility, and integration with modern surgical systems are encouraging healthcare facilities to upgrade their electrosurgical infrastructure. As surgeons increasingly prioritize precision, safety, and efficient operating-room workflows, advanced generators are becoming more important to the overall performance of ultrasonic surgical systems. Their expanding role in supporting sophisticated surgical procedures is therefore strengthening segment growth.

End Use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)

Hospitals led the ultrasonic electrosurgical devices market with a 51.41% share in 2026, primarily because they perform a broad range of complex and high-volume surgical procedures requiring advanced tissue management technologies. Hospitals have access to comprehensive surgical infrastructure and multidisciplinary teams, supporting the adoption of ultrasonic devices across general surgery, gynecology, oncology, and other specialties. The continued shift toward minimally invasive techniques is also encouraging hospitals to integrate energy-based surgical technologies that can improve procedural precision and workflow efficiency.

Ambulatory surgical centers are the fastest-growing end-use segment as healthcare delivery continues to shift toward outpatient and minimally invasive procedures. These facilities increasingly require compact, efficient surgical technologies that can support effective procedures while promoting shorter recovery and streamlined patient throughput. Ultrasonic electrosurgical devices align with these requirements by providing controlled tissue dissection and coagulation within outpatient surgical workflows. Growing preference for cost-efficient procedural settings and expanding availability of advanced surgical capabilities outside traditional hospitals are further supporting adoption.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Product	Generators, Consumables	Consumables	Generators
End Use	Hospitals, Ambulatory Surgical Centers, Others	Hospitals	Ambulatory Surgical Centers
Type	High-intensity Focused Ultrasonic (HIFU)Ablators, Magnetic Resonance-guided Focused Ultrasonic (MRGFUS)Ablators, Ultrasonic Surgical Ablation Systems, Shock Wave Therapy Systems	High-intensity Focused Ultrasonic (HIFU)Ablators	Ultrasonic Surgical Ablation Systems
Application	Cardiology, Gynecology, General Surgery, Urology, Bariatric Surgery, Others	Cardiology	Gynecology

Competitive Landscape and Market Positioning

Leading companies in the ultrasonic electrosurgical devices market:

1. Johnson & Johnson (United States)

2. Olympus Corporation (Japan)

3. Medtronic plc (Ireland)

4. Söring GmbH (Germany)

5. BOWA-electronic GmbH & Co. KG (Germany)

6. Misonix Inc. (United States)

7. Reach Surgical Inc. (United States)

8. SonaCare Medical LLC (United States)

9. Miconvey Technologies Co. Ltd. (China)

10. Advanced Instrumentations (United States)

The ultrasonic electrosurgical devices market is advancing through rapid integration of precision-focused surgical technologies aimed at improving procedural accuracy and patient safety. Continuous innovation is enabling more refined energy control systems that enhance surgical efficiency. New product developments are increasingly focused on minimally invasive applications and improved operational control. Strong research momentum is supporting next-generation device performance improvements across surgical environments.

Industry Development/News

Company Name	Date	Key Development
Olympus Corporation	Oct-25	Olympus launched THUNDERBEAT II, a next-generation hybrid energy device for soft tissue management in laparoscopic and open surgery. The system is designed to enable faster dissection and improved hemostasis, reflecting continued innovation in ultrasonic and hybrid surgical energy platforms used in advanced surgical procedures and minimally invasive operating environments.
Johnson & Johnson MedTech	Mar-25	Johnson & Johnson MedTech introduced the DUALTO Energy System, an integrated surgical energy platform combining multiple modalities for open and minimally invasive surgery. The system is designed to improve operational efficiency and device management, and is positioned for future integration with robotic surgery systems, reinforcing its surgical energy ecosystem strategy.
KARL STORZ	Aug-24	KARL STORZ completed its acquisition of Asensus Surgical, securing access to the LUNA robotic system. The transaction strengthens its presence in advanced surgical robotics and energy-enabled minimally invasive surgery technologies, expanding its portfolio across digital surgery and integrated operating room ecosystems.
Medtronic	Sep-20	Medtronic launched the Sonicision cordless ultrasonic dissection system designed for precision tissue cutting across multiple surgical specialties. The device serves as an alternative or adjunct to traditional surgical tools such as scalpels and electrosurgery systems, supporting broader adoption of ultrasonic energy-based surgical technologies.
Lexington Medical	Jul-20	Lexington Medical entered a partnership with BOWA Medical to co-market the LOTUS and AEON surgical energy portfolios across multiple global markets. The collaboration supports broader international distribution of ultrasonic and advanced bipolar energy devices used in diverse surgical procedures.